Self-efficacy predicts fibromyalgia symptomatology

Self-efficacy predicts fibromyalgia symptomatology
Self-efficacy is a significant predictor of fibromyalgia symptomatology, according to a study published online July 17 in Arthritis Care & Research.

(HealthDay) -- Self-efficacy is a significant predictor of fibromyalgia symptomatology, according to a study published online July 17 in Arthritis Care & Research.

Charles Van Liew, from the San Diego State University, and colleagues conducted an autoregressive path analysis to examine the pathways among depression, self-efficacy, pain, and physical functioning in 462 patients (441 women) followed for one year.

The researchers found that, across time, self-efficacy was the only significant predictor of depression, physical functioning, and pain intensity ratings. Self-efficacy at one year was predicted by physical functioning at six months. Within the model, no other factors were significantly associated with self-efficacy.

"Our model suggests a synergistic approach -- specifically, using exercise and therapy combined to have patients experience improvements in functioning while simultaneously reprocessing these improvements and the implications of these improvements for their ability to manage their symptoms," the authors write. "This should enhance feelings of self-efficacy, which should have the greatest, most extensive, and longest lasting benefits for those with fibromyalgia syndrome."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Gabapentin may treat fibromyalgia pain

Jun 11, 2007

U.S. scientists say the anticonvulsant medication gabapentin might be effective in treating pain and other symptoms arising from fibromyalgia.

Recommended for you

Cartilage actively contributes to arthritis

Sep 12, 2014

Melbourne researchers have discovered that cartilage plays an active role in the destruction and remodelling of joints seen in rheumatoid arthritis, rather than being an 'innocent bystander' as previously ...

Blocking one receptor could halt rheumatoid arthritis

Sep 10, 2014

Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis—and ...

User comments